Pfizer

President Donald Trump's inaugural committee raised $239 million, a new fundraising report shows, buoyed by million-dollar contributions from major companies and business executives.

News and commentary from the endocrinology world

The House Oversight Committee has launched an investigation into 23andMe over the risk of the company selling customers' genetic material and information amid the biotech firm's bankruptcy.

Fremanezumab shows safety, efficacy in phase III trial of pediatric patients

Oral semaglutide, already approved for type 2 diabetes, led to a reduction in CV events in patients with established atherosclerotic disease, CKD, or both.

Keith Meister, Corvex Management's chief investment officer, will join Illumina's board starting March 28. He's no stranger to the world of biotech.

/PRNewswire-PRWeb/ -- Women We Admire is pleased to announce The Rising Star Women Leaders in Medicine for 2025. Medicine is a constantly evolving field that...

The report said GSK's former head of vaccine development, Philip Dormitzer, who joined the company after working at rival Pfizer, had told his GSK colleagues about the delay.

A rare joint effort launched by the Biden administration and embraced by the Trump White House brought two Palestinian children with cancer from Gaza to the U.S. for treatment this week, multiple sources tell NBC News

CEO Julie Sweet told investors on Thursday that the company was experiencing a notable slowdown in securing new contracts from the US government.

Acute liver failure developed in patient receiving Elevidys

In men with PSA persistence, higher pre-op PSA tied to lower mortality, suggesting overtreatment

The National Institutes of Health is terminating dozens of studies examining why people are hesitant about vaccines and how to increase uptake. mRNA vaccine research may be on the chopping block, too.

Five years ago, the WHO declared Covid-19 a pandemic. Today we risk undermining the medical technology that helped us survive.

Yes, study suggests, but results may not represent a meaningful impact, expert says

Half of patients who used delgocitinib cream for chronic hand eczema had a profound response, and a third who stopped treatment stayed clear or nearly clear for 8 weeks.

Plus, Pfizer considers moving more production to the US and obesity is on the rise worldwide

Novo Nordisk CEO Lars Fruergaard Jorgensen said the company, which makes Ozempic and Wegovy, is not "immune" to tariffs

Nvidia today announced GTC 2025, the world's premier AI conference, will return March 17 to March 21 to San Jose, California.

Now that Novavax has been added to the revamped COVID vaccines, you'll want to make sure to check on the changes to cost and more.